Statement of Organization, Functions, and Delegations of Authority, 1417-1419 [2015-00145]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 80, Number 6 (Friday, January 9, 2015)]
[Notices]
[Pages 1417-1419]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00145]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 79 FR 32739-32740, dated June 7, 2014) is 
amended to reflect the reorganization of the Global Immunization 
Division within the Center for Global Health.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title and the mission and function 
statements for the Global Immunization Division (CWK) and insert the 
following:
    Global Immunization Division (CWK). The Global Immunization 
Division (GID) protects the health of Americans and global citizens by 
preventing disease, disability, and death worldwide from vaccine-
preventable diseases. In carrying out its mission, GID: (1) Provides 
national leadership and coordination of the Center for Global Health 
(CGH) efforts to eradicate polio; eliminate measles and rubella in 
World Health Organization (WHO) regions; strengthens global 
surveillance to prevent, detect, and respond to vaccine preventable 
diseases; strengthens routine immunization programs; introduces new and 
under-utilized vaccines; and promotes safe injection practices in 
collaboration with international organizations and CDC Centers/
Institute/Offices (CIOs); (2) provides technical expertise to global 
partners--WHO, United Nations International Children's Emergency Fund 
(UNICEF), Global Alliance for Vaccine Immunization (GAVI), and the Bill 
and Melinda Gates Foundation (BMGF)--involved in global immunization 
activities and participates in international advisory group meetings on 
immunization issues; (3) ensures provision of technical expertise on 
evidence-based research, strategies, and policy at global and country 
levels in collaboration with multilateral and bilateral partners; (4) 
collaborates with other countries and administers grants to WHO, Pan 
American Health Organization (PAHO), UNICEF, and other international 
partners and advocacy groups as appropriate for the provision of 
technical, programmatic, and laboratory support, and vaccine 
procurement for initiatives to support global immunization targets; (5) 
improves surveillance for polio, measles, rubella, and other vaccine 
preventable diseases by working with individual countries and the WHO 
regional offices to improve surveillance and to collaborate with groups 
within and outside CDC to expand environmental surveillance; (6) 
achieves global immunization targets by supporting the strengthening of 
the implementation of national immunization policies; (7) strengthens 
appropriate vaccination policy development and implementation, 
identifies barriers to vaccine acceptance, and develops communication 
strategies to promote vaccine uptake and disease reduction; (8) 
develops strategies to improve the technical skills and problem-solving 
abilities of program managers and health care workers in other 
countries; (9) prepares immunization articles based on findings for 
publication in international professional journals and for presentation 
at international conferences; and (10) provides technical and 
operational leadership for CDC's activities in support of the 
initiatives.
    Office of the Director (CWK1). (1) Provides leadership, management, 
and oversight for all division activities including administrative, 
budget, finance, research, workforce development, management and 
operations; (2) assists leadership in the formulation and defense of 
GID budget requests, and monitors and seeks strategies to mitigate 
division risks; (3) provides coordination and oversight of the 
division's personnel actions including liaison with CGH and CDC's human 
resource office; (4) provides oversight for workforce planning, 
recruitment, deployment, field staff support, professional development, 
and monitoring and evaluation; (5) develops and promotes partnerships 
with other organizations to support global immunization activities and 
works closely with partners in academia; (6) liaises and coordinates 
with other CDC offices engaged in global immunization activities; (7) 
provides leadership and oversight for scientific and programmatic 
activities related to the implementation of GID's objectives and 
ensures that the research and economic portfolios are integrated across 
the branches and with field activities; (8) identifies program policy 
priorities through strategic planning and other processes as 
appropriate; (9) clears all scientific publications from the division 
working in close collaboration with management of GID; (10) provides 
coordination of the division's communications activities including 
liaison with other CDC communications offices and those of our partner 
agencies; (11) represents CDC, CGH, and the division at global and 
national meetings and other fora for global immunization activities; 
(12) provides

[[Page 1418]]

oversight for all Embassy/International Cooperative Administrative 
Supportive Services costs for the division's field staff; and (13) 
works in close collaboration and interfaces with CGH and other CIOs, 
global immunization partners, and other collaborating partners in 
matters relating to program development and research.
    Polio Eradication Branch (CWKB). (1) Achieves global polio 
eradication in partnership with the Global Polio Eradication Initiative 
(GPEI) and optimize polio investments toward future health goals; (2) 
acts as CDC's lead for polio eradication activities in countries within 
Africa in partnership with GPEI; (3) works with polio free regions to 
strengthen their efforts to remain polio-free, particularly in the 
areas of surveillance, outbreak preparedness, containment and legacy 
planning; (4) improves surveillance for polio by working with 
individual countries, WHO regional offices, and groups within and 
outside CDC to expand environmental surveillance; (5) is prepared to 
respond quickly to outbreaks of wild poliovirus and circulating 
vaccine-derived polioviruses; (6) leads work in countries at high risk 
for polio; (7) leads activities to achieve poliovirus containment by 
the required deadlines; (8) oversees technical aspects of specific 
polio activities funded by CDC; (9) prepares countries for 
certification; (10) leads or collaborates in research to support polio 
eradication goals; (11) identifies opportunities to leverage polio 
eradication assets to promote sustainable improvements in routine 
immunization systems, in collaboration with the Immunization Systems 
Branch; (12) defines and ensures a sustainability legacy for the polio 
eradication program in addition to polio eradication itself and 
identifies opportunities to implement strategies toward this goal; (13) 
coordinates with key partners within and outside CDC; (14) promotes the 
National Stop Transmission of Polio (NSTOP)program; (15) develops 
priorities for CDC's involvement in polio eradication research and 
innovation activities; (16) collects and analyzes data on wild polio 
virus and vaccine perceived polio virus incidence, surveillance 
performance and immunization status based on acute flaccid paralysis 
surveillance and supplemental immunization activities implementation 
quality; (17) provides support to regional and country teams in 
assessing risk of outbreaks of wild poliovirus and circulating vaccine-
derived polioviruses; responding to outbreaks; planning and 
implementing mitigating activities to prevent outbreaks; improving 
surveillance; and assisting in development of documentation to support 
certification and containment; and (18) supports the completion of 
global polio eradication through strengthening surveillance, innovation 
and research.
    Accelerated Disease Control and Vaccine Preventable Diseases 
Surveillance Branch (CWKC). (1) Achieves accelerated disease control 
goals for vaccine preventable diseases (VPD), with a high focus on 
eliminating measles and rubella in WHO regions in partnership with the 
Measles and Rubella Initiative (MRI), and strengthening global 
surveillance to prevent, detect and respond to VPDs; (2) leads global 
and regional measles elimination goals; (3) provides expert technical 
input toward development, evaluation, and improvement of program 
activities and strategies to mitigate risk and achieve global and 
regional measles elimination goals; (4) monitors measles incidence and 
risk through development and analysis of high quality surveillance data 
and risk estimates, estimating burden of disease/death and verifying 
elimination; (5) develops and maintains outbreak preparedness and 
respond rapidly to outbreaks; (6) oversees the technical aspects of 
measles activities funded by CDC; (7) leads global and regional rubella 
control and elimination goals; (8) provides expert technical input to 
countries on the development and implementation of national plans of 
action for rubella vaccine introduction and the control and elimination 
of rubella and congenital rubella syndrome; (9) leads activities of the 
MRI, including participation on working groups, as appropriate; (10) 
strengthens labs and lab networks to ensure appropriate and timely 
specimen collection, testing, and result dissemination; (11) develops 
and maintains outbreak control strategies, including developing 
mathematical models to estimate the target age range for achieving 
program goals; (12) provides technical support to reach global or 
regional goals for control of targeted VPDs; (13) provides expert 
technical input towards development, evaluation, and improvement of 
program activities and strategies to mitigate risk and achieve global 
and regional VDP control goals; (14) monitors prevalence, incidence and 
risk through development and analysis of high quality surveillance data 
and risk estimates, estimating burden of disease/death and verifying 
elimination; (15) conducts research and evaluation to maximize the 
cost-effectiveness of elimination and outbreak control strategies; (16) 
oversees the technical aspects of targeted VPD activities funded by 
CDC; (17) provides ongoing support for development, implementation, 
quality, and use of VPD surveillance; (18) evaluates VPD surveillance 
systems and improves the quality, analysis, and use of surveillance 
data for program action and decision-making; (19) provides technical 
assistance in establishing and maintaining surveillance for diseases 
prevented by new or underutilized vaccines; (20) conducts research and 
evaluation to maximize surveillance performance and cost-effectiveness; 
and (21) leads innovative research and development to strengthen 
surveillance and improve laboratory diagnosis.
    Immunization Systems Branch (CWKD). (1) Achieves global 
immunization targets by supporting the strengthening of the 
implementation of national immunization policies; identifies strategies 
to increase vaccine demand; promotes the appropriate introduction and 
use of quality vaccines; and strengthens routine immunization program 
delivery and equitable access to vaccines, while promoting synergies 
through the child health agenda; (2) leads development and 
implementation of effective communication strategies that address 
issues related to vaccine demand and uptake; (3) identifies caregiver, 
provider, and community determinants that affect vaccine demand, in 
order to develop evidence-based strategies to remove barriers and 
increase demand for immunization; (4) evaluates vaccine policy 
development, implementation, and impact, and advocates for policies 
demonstrated to support acceptance of vaccine; (5) accelerates progress 
toward achieving the millennium development goals of mortality 
reduction and disease prevention by advocating and promoting the 
appropriate and equitable introduction of new and underutilized 
vaccines; (6) builds evidence and rationale for vaccine introduction; 
(7) secures WHO-prequalification; (8) provides technical and 
programmatic assistance to countries to introduce new and underutilized 
vaccines into their national immunization programs; (9) evaluates 
effectiveness of introduction of new and underutilized vaccines in 
terms of uptake, impact on existing immunization program function, and 
potential impact on disease burden; (10) works with VPD Surveillance 
Team and CDC subject matter experts to build country capacity for 
future introduction of new and underutilized vaccines; (11)

[[Page 1419]]

leads inactive polio virus introduction to immunization systems in oral 
polio virus using countries as mandated through the Immunization 
Management Group of the Global Polio Eradication Initiative; improves 
routine immunization systems globally (or improves access to and 
utilization of vaccines globally through strengthening of routine 
immunization systems); (12) develops, evaluates, and scales-up 
evidence-based strategies to tackle inequities in access to and 
delivery of vaccines; (13) develops evaluates, and scales-up 
comprehensive and coordinated approaches to integrate immunization 
services; (14) promotes innovation to improve routine immunization 
program efficiencies and increase coverage and impact; (15) conducts 
advocacy to national programs on the need to strengthen immunization 
system abilities to monitor, assess and respond to issues related to 
vaccine safety; and (16) conducts operational research to identify and 
test interventions to improve the access and utilization of 
immunization services and provide guidance on what areas are in need of 
workforce capacity building activities.
    Strategic Information and Workforce Development Branch (CWKE). (1) 
Builds workforce, systems, and information capacity to effectively 
deliver immunization services in selected countries; (2) provides 
technical assistance and support, guidance, and advice on statistical 
analysis and study design, data management, and data integrity to the 
GID; (3) provides statistical expertise to support internal data 
management needs of the division and field staff (standard setting for 
record keeping, archiving, ensuring reproducibility of analyses); (4) 
collaborates with branch and team level leadership and GID management 
to ensure that statistical and methodological standards continue to 
remain an integral part of planning, conduct, and review of science and 
program within GID including with the context of the official clearance 
process; (5) provides GID statistical representation on internal and 
external committees and work groups and at relevant meetings, 
workshops, and fora; (6) promotes capacity building for polio, other 
VPDs and immunization functions in partnership with WHO and UNICEF 
through recruiting, coordinating training of, and deploying STOP teams; 
(7) promotes capacity building for polio, other VPDs and immunization 
functions in partnership with WHO and UNICEF; (8) leads the development 
of strong national immunization programs and systems through workforce 
capacity development; (9) ensures recruitment for training and WHO 
deployment for each STOP team; (10) creates and maintains strategic 
partnerships and collaborations and provides technical assistance to 
develop and evaluate sustainable programs aimed at increasing capacity 
and effectiveness of workforce responsible for implementing 
immunization programs; (11) conducts operational research to identify, 
implement and evaluate interventions aimed at improving immunization 
(or integrated public health) workforce effectiveness and contributes 
to the scientific knowledge base regarding interventions aimed at 
improving immunization workforce effectiveness; (12) leads 
strengthening routine immunization systems as mandated through the 
Immunization Management Group of the Global Polio Eradication 
Initiative; and (13) leads the development of strong immunization 
systems through improving quality, management, and use of immunization 
data and providing specific technical skills for program evaluation to 
include strategic information, informatics and information systems, 
program evaluation, polio eradication and endgame strategy, and 
operational research.

James D. Seligman,
Acting Chief Operating Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2015-00145 Filed 1-8-15; 8:45 am]
BILLING CODE 4160-18-P